Coronavirus and Infusion Therapy
If your IBD medication requires scheduled infusions, you may have questions about how to maintain a safe environment for yourself and your loved ones during this uncertain time. If your treatment requires an infusion, please do not skip these appointments. Infusion medications are meant to be given on a set schedule to control the progression of disease, and it’s important to maintain the schedule set by your healthcare provider. Please refer to our IBD Medications page for specific medication guidance.
It's important to communicate with your provider about any questions or concerns you may have. When talking with your healthcare team, remember to discuss your specific case and preferences in terms of schedule (morning, afternoon, evening infusions). It’s also important to discuss the risks and benefits of receiving your prescribed therapy during a community outbreak of COVID-19. Again, you should not stop receiving your infusions without first consulting your healthcare team.
Infusion medications for IBD may include the following:
- Cyclosporine (Gengraf®, Sandimmune®)
- Infliximab (Remicade®)
- Infliximab abda (Renflexis®)
- Infliximab dyyb (Inflectra™)
- Infliximab qbtx (IXIFI™)
- Methylprednisolone (A-Methapred®, Depo-Medrol®, Medrol Dosepak®, Solu-Medrol®)
- Natalizumab (Tysabri®)
- Ustekinumab (Stelara®)
- Tacrolimus (Prograf®)
- Vedolizumab (Entyvio®)
In addition to IBD medications, there are other treatments requiring IV infusion which may include antibiotics to treat infections, vitamin and mineral supplementation, and nutritional support therapy.
The National Infusion Center Association educates and provides resources for patients in need of intravenous and injectable medications. To find out more information visit: https://infusioncenter.org/
This content was developed in partnership with the National Infusion Center Association. Review was also provided by the Crohn’s & Colitis Foundation’s National Scientific Advisory Committee.
Last updated 4/17/20